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Abstract 
Cogan syndrome and lichen planus represent two autoimmune disorders. Cogan syndrome is 
a very rare type of ANCA-negative vasculitis affecting the eyes and vestibulocochlear system. 
It has been associated with other autoimmune disorders, none of them showing any lichenoid 
inflammation. We herein report the first case of a patient that suffered from Cogan disease 
and developed isolated lichen planus on all nails a few years after the first diagnosis. The com-
bination of two autoimmune disorders is not unusual and raises the question of common im-
munogenetic pathomechanisms. © 2019 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Cogan syndrome (CS) and nail lichen planus represent two autoimmune disorders. Both 
have been associated with other autoimmune disorders. So far only two cutaneous diseases, 
none of them lichenoid, were described in patients with CS. 
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Case Report 
We report on a 49-year-old patient that was referred for nail consultation for evaluation 
of a progressive onychodystrophy involving most of his fingernails. The patient was treated 
for CS, which had been diagnosed 15 years prior to this consultation, with auditory and ocular 
involvement. At that time, the therapy included systemic corticosteroids, azathioprine, and 
cyclophosphamide. Cessation of the acute inflammation was achieved, but the hearing impair-
ment persisted. There was no personal or family history of inflammatory skin diseases or 
other autoimmune disorders. 
Clinical examination revealed thinned nail plates with a rough surface, longitudinal fis-
suring, and distal onycholysis of eight fingernails. Both the thumb and big toenails showed a 
thickened nail plate with xanthonychia (Fig. 1). Otherwise, examination of the whole body in-
cluding the hair and mucous membranes was unremarkable. A lateral longitudinal nail biopsy 
was performed, and light microscopy studies showed a characteristic dense band-like lichen-
oid lymphocytic infiltrate in the proximal nail matrix and undersurface of the proximal nail 
fold (Fig. 2). With this clinicopathological correlation, the diagnosis of nail lichen planus was 
confirmed. 
Discussion 
CS is a rare type of ANCA-negative vasculitis with predominant involvement of the eyes 
and vestibulocochlear system. Typical symptoms include keratitis and a Ménière-like triad of 
vertigo, tinnitus, and sensorineural hearing loss that often persists after remission [1]. Sys-
temic manifestations of vasculitis are present in up to 50% of the patients, with complaints 
such as fever, arthralgia, and myalgia [1–4]. Aortitis can evolve as a serious complication of CS 
[4, 5]. Systemic corticotherapy associated with disease-modifying antirheumatic drugs and 
TNF inhibitors currently represents the main treatment of CS. Infliximab showed superior ef-
fects in vestibuloauditory outcomes in a retrospective study [6]. 
In the current literature, pyoderma gangrenosum and vasculitis were described as the 
only cutaneous manifestations in patients with CS [7]. So far, no lichenoid reactions were re-
ported. 
Nail involvement of lichen planus may occur as an isolated finding but more often in as-
sociation with other mucocutaneous manifestations [8]. Involvement of the nail matrix char-
acteristically leads to thinning of the nail and roughening of the nail surface, called trachy-
onychia, as well as longitudinal ridging and fissuring. Subungual hyperkeratosis and distal on-
ycholysis as signs of nail bed involvement are less frequent [9]. 
Immune dysregulation with a predominantly CD8+ T-cell reaction plays an essential role 
in the pathophysiology of the disease [10]. 
The combination of two or even more autoimmune disorders is not unusual. It is often 
explained by immunogenetic relations between these diseases. However, until now, no such 
immunogenetic links between CS and nail lichen planus have been known. Thus, it remains 
speculative whether this association is just fortuitous or based on a common pathomecha-
nism. 
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Fig. 1. a–d The clinical features involve distal onycholysis of almost all fingernails (a–c) and the big toenails 
(d) due to nail bed involvement. The majority of the nails show thinning of the nail plate and xanthonychia. 
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Fig. 2. Lateral longitudinal nail biopsy showing a dense band-like lymphocytic infiltrate in the matrix typi-
cal of nail lichen planus. 
 
